Sakai Shinobu, Otake Eri, Toida Toshihiko, Goda Yukihiro
Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Chem Pharm Bull (Tokyo). 2007 Feb;55(2):299-303. doi: 10.1248/cpb.55.299.
Twelve "health foods" products containing chondroitin sulfate (CS) were purchased from the Japanese market and the origin of the CS was investigated by conducting disaccharide compositional analysis after enzymatic depolymerization and by 1H-NMR spectroscopy. Nine of the 12 products had labels indicating that the origin of the CS was shark cartilage. However, two of them were found to contain mammalian CS. Next, we compared the ratio of the sulfate group to the galactosamine residue after the acid hydrolysis of CS. The results suggest that all of the CS from sharks had a ratio of more than 1.0, while the CS from mammals had a ratio of less than 1.0. Since this comparative analysis does not require expensive purified enzyme, it would be an economical way to identify the origin of CS in "health foods." Being able to determine the origin of the ingredients in natural products is very important for ensuring their quality, safety, and efficacy. Therefore, we think that regulatory requirements for accurately indicating the origin of "health foods" and effective enforcement of these requirements are needed.
从日本市场购买了12种含硫酸软骨素(CS)的“健康食品”产品,并通过酶解聚后进行二糖组成分析和1H-NMR光谱法研究了CS的来源。12种产品中有9种标签标明CS的来源是鲨鱼软骨。然而,其中两种被发现含有哺乳动物来源的CS。接下来,我们比较了CS酸水解后硫酸基团与半乳糖胺残基的比例。结果表明,所有鲨鱼来源的CS比例都大于1.0,而哺乳动物来源的CS比例小于1.0。由于这种比较分析不需要昂贵的纯化酶,它将是一种鉴定“健康食品”中CS来源的经济方法。能够确定天然产品中成分的来源对于确保其质量、安全性和功效非常重要。因此,我们认为需要对“健康食品”准确标明来源制定监管要求并有效执行这些要求。